Conferences and symposiums Open symposium in Nobel Forum: Oxygen sensing, Cancer and Beyond

09-12-2019 8:30 am - 6:00 pm Add to iCal
Campus Solna Nobel Forum, Nobels väg 1, Solna

Welcome to an open symposium celebrating the achievements of The Nobel Prize in Physiology or Medicine on 9 December between 08:30-18:00. No registration required.

Topic of the day

"Oxygen Sensing, Cancer and Beyond"

Host

Department of Microbiology, Tumor and Cell Biology

Organisers

Susanne Schlisio and Qing Zhang.

Confirmed speakers

Keynote Speakers:

Celeste Simon, University of Pennsylvania and Randall Johnson, Karolinska Institutet

Other speakers:

  • Mircea Ivan, Indiana Uni. School of Medicine
  • William Kim, UNCLineberger Cancer Center
  • Haifeng Yang, Thomas Jefferson University
  • Peppi Koivunen, University of Oulu
  • Julie Aurore Losman, Dana-Farber Cancer Institute
  • Matthew Oser, Dana-Farber Cancer Institute
  • Vidyasagar Koduri, Dana-Farber Cancer Institute
  • Qing Zhang, UT Southwestern
  • Samuel Kent McBrayer, UT Southwestern
  • James Brugarolas, UT Southwestern
  • Elizaveta Benevolenskaya, University of Illinois at Chicago
  • Martin Bergö, Karolinska Institutet
  • Susanne Schlisio, Karolinska Institutet
  • Remarks by  the Nobel Prize laurate William G. Kaelin Jr
08:30-09:00
Registration and Coffee
09:00-09:10
Welcome: Susanne Schlisio (Karolinska Institutet
09:10-12:35
SESSION 1

Chairs: Dr. Qing Zhang and Dr. James Brugarolas, UT Southwestern

09:10-09:45
Keynote Lecture: "Oxygen and Physiology: the untold story"

Dr. Randall Johnson, Karolinska Institutet

09:45-10:10
“NORS: A Novel Noncoding O2-Sensitive Regulator of Sterol Biosynthesis”

Dr. Mircea Ivan, Indiana University School of Medicine

10:10-10:35
“The dark side of 2-oxoglutarate”

Dr. Julie-Aurore Losman, Dana-Farber Cancer Institute

10:35-10:55
Coffee and posters
10:55-11:20
“Oxygen and oncometabolite sensing by 2-oxoglutarate-dependent enzymes”

Dr. Peppi Koivunen , University of Oulu

11:20-11:45
“Redox regulation of lung cancer metastasis”

Dr. Martin Bergö, Karolinska Institutet

11:45-12:10
"The analysis of PBRM1, the second highest mutated gene in kidney cancer”

Dr. Haifeng Yang, Thomas Jefferson University

12:10-12:35
“Improving Immunotherapy for Bladder Cancer”

Dr. William Kim, UNC Lineberger Comprehensive Cancer Center

12:35-13.50
Lunch and posters
13:50-14:00
Remarks by: Dr. William G. Kaelin, Nobel Prize laurate
14:00-18:00
SESSION 2

Chairs: Dr. Julie-Aurore Losman, Dana-Farber and Dr. William Kim, UNC

14:00-14:35
Keynote Lecture: “Hypoxia, Metabolism, and Tumor Progression”

Dr. Celeste Simon, University of Pennsylvania

14:35-15:00
“Oxygen sensitive regulation of mitochondrial mass”

Dr. Susanne Schlisio, Karolinska Institutet

15:00-15:25
“At the crossroads of epigenetics and angiogenesis: targeting the undruggable”

Dr. James Brugarolas, UT Southwestern

15:25-15:50
“HIF-independent synthetic lethality between CDK4/6 inhibition and VHL loss"

Dr. Hilary Nicholson, Dana-Farber

15:50-16:10
Coffee and posters
16:10-16:35
“Metabolic Reprogramming by IDH1 Mutations in Glioma”

Dr. Samuel Kent McBrayer, UT Southwestern

16:35-17:00
“Epigenetic and transcriptional events enabling emergence of drug resistant states”

Dr. Elizaveta Benevolenskaya, University of Illinois at Chicago

17:00-17:25
“Therapeutic Targets in Small Cell Lung Cancer that are Synthetic Lethal with pRB Loss”

Dr. Matthew Gilbert Oser, Dana-Farber Cancer Institute

17:25-17:50
“A Selection Screen to Identify Spautin-1, A Degrader of IKAROS”

Dr. Vidyasagar Koduri, Dana-Farber Cancer Institute

17:50-18:00
Concluding remarks

Contact

Susanne Schlisio Principal researcher